Clinical Trials Search | Clareo Health

Showing 1-2 of 2 trials

Post-marketing Safety Surveillance of Qizhi Tongluo Capsules:a Registry Study.

NCT04479553

This registry aims to monitor the safety of Qizhi Tongluo Capsules and to identify the potential risk factors for its adverse drug reactions.

Safety SurveillanceAdverse Drug EventsAdverse Drug Reactions+2 more

Zhong Wang30,000 participantsStarted Aug 2020

Changzuo, Guangxi, China • Fangchenggang, Guangxi, China • Nanning, Guangxi, China +11 more locations

COMPLETED

Post-marketing Safety Surveillance of Compound Kuh-seng Injection: a Registry Study

NCT02239237

This registry aims to monitor the safety of Compound Kuh-seng Injection and to identify the potential risk factors for the adverse drug reactions. Compound Kuh-seng Injection is a kind of natural compound injection extracted from herbs Kuh-seng (Radix Sophorae Flavescentis) and Rhizoma Heterosmilacis Japonicae.

Safety SurveillanceAdverse Drug EventsAdverse Drug Reactions+2 more

Zhong Wang30,283 participantsStarted Sep 2014

Handan, Hebei, China • Handan, Hebei, China • Shijiazhuang, Hebei, China +26 more locations

Data from ClinicalTrials.govTerms

Filters

Filters

Post-marketing Safety Surveillance of Qizhi Tongluo Capsules:a Registry Study.

Post-marketing Safety Surveillance of Compound Kuh-seng Injection: a Registry Study

Post-marketing Safety Surveillance of Qizhi Tongluo Capsules:a Registry Study.

Post-marketing Safety Surveillance of Compound Kuh-seng Injection: a Registry Study